Global Lungs in Vitro Model Market Research Report 2026(Status and Outlook)
Lungs in Vitro Models are advanced biological systems designed to mimic the complex cellular structures, physiological barriers, and dynamic mechanical environment of the human lung outside the body. These models range from simple two-dimensional (2D) cell monolayers and complex three-dimensional (3D) lung organoids to cutting-edge Lung-on-a-Chip microfluidic devices. The primary purpose of these models is to recreate the crucial air-liquid interface and the alveolar-capillary barrier, allowing researchers to study gas exchange, particle deposition, drug absorption kinetics, and the pathogenesis of respiratory diseases like COVID-19 and COPD. By incorporating specialized features such as cyclic mechanical strain (simulating breathing) and fluid flow (simulating blood circulation), these models offer a powerful, high-fidelity alternative to traditional animal testing.Market Development Opportunities & Main Driving FactorsThe Lungs in Vitro Models market is entering a golden age of exponential growth, primarily driven by the global imperative for high-precision, physiologically relevant tools in drug development and the regulatory push for alternatives to animal testing. Governments and major regulatory bodies (such as the US FDA and European EMA) are actively encouraging and supporting the use of in vitro models, particularly in toxicology and early-stage drug screening, opening significant policy windows for startups and established vendors focused on organoid and organ-on-a-chip technologies. The key market opportunities center on precision medicine for respiratory diseases and environmental toxicology research. Lung models can accurately simulate the pathophysiology of complex diseases like asthma, COPD, pulmonary fibrosis, and COVID-19, dramatically shortening the drug discovery cycle and reducing the risk of late-stage clinical trial failure. For investors, this represents a niche market characterized by high technical barriers, strong customer stickiness, and high-profit margins, especially when integrated with AI-driven drug screening platforms, where value can grow exponentially.Market Challenges, Risks, & RestraintsDespite their revolutionary potential, the commercialization and standardization of Lungs in Vitro Models face significant technical and business challenges. The primary challenge is the complexity and reproducibility of the models. High-fidelity lung-on-a-chip or organoid models require intricate cell culture conditions, precise microfluidic structures, and accurate simulation of respiratory mechanical stress. This leads to difficulties in controlling batch-to-batch variability, hindering their adoption in high-throughput applications within the pharmaceutical industry. The high initial cost and operational complexity represent another restraint. Organ-on-a-chip technology, in particular, requires expensive specialized equipment and highly trained personnel, limiting its widespread adoption in smaller labs and the In Vitro Diagnostics (IVD) sector. Market risks are centered on the uncertainty of regulatory acceptance. Despite policy encouragement, the regulatory process for the full validation and adoption of novel in vitro models as a preclinical Gold Standard alternative is still evolving, and any uncertainty in validation results impacts pharmaceutical companies' confidence in large-scale adoption.Downstream Demand TrendsFuture downstream demand trends will be geared toward personalization, multi-organ integration, and automation. In the drug development sector, the demand is shifting from using general cell lines to utilizing patient-induced pluripotent stem cell (iPSC)-derived lung models to enable true precision toxicology and pharmacodynamic assessment. Customers are seeking models that can simulate an individual patient's response to specific drugs, requiring model vendors to provide robust cell differentiation and quality control capabilities. Another critical trend is the integration into Multi-Organ Systems (Body-on-a-Chip), connecting lung models with other organ models (like liver and heart) to simulate the drug's systemic Absorption, Distribution, Metabolism, and Excretion (ADME) process, thereby providing a more comprehensive assessment of safety and efficacy. Furthermore, automation and standardization are key to increasing industry penetration, with downstream users increasingly demanding the integration of automated liquid handling, data acquisition, and high-throughput imaging capabilities to achieve industrial-scale drug screening throughput.
The global Lungs in Vitro Model market size was estimated at USD 267.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 12.90% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Lungs in Vitro Model market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Lungs in Vitro Model market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Lungs in Vitro Model market.
Global Lungs in Vitro Model Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Mattek (Sartorius)
Dynamic42
SynVivo
Lonza
Epithelix
Oncotheis
Emulate
Mimetas
Tissuse
Insphero
CN Bio Innovations
AlveoliX
Market Segmentation (by Type)
2D Cell Models
3D Cell Models
Organ-on-a-Chip Models
Market Segmentation (by Application)
Drug Discovery and Toxicology
Basic Research
Physiological Research
Stem Cell Research and Regenerative Medicine
Others
Geographic Segmentation
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Lungs in Vitro Model Market
Overview of the regional outlook of the Lungs in Vitro Model Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Lungs in Vitro Model Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Lungs in Vitro Model, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Lungs in Vitro Model market size was estimated at USD 267.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 12.90% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Lungs in Vitro Model market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Lungs in Vitro Model market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Lungs in Vitro Model market.
Global Lungs in Vitro Model Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Mattek (Sartorius)
Dynamic42
SynVivo
Lonza
Epithelix
Oncotheis
Emulate
Mimetas
Tissuse
Insphero
CN Bio Innovations
AlveoliX
Market Segmentation (by Type)
2D Cell Models
3D Cell Models
Organ-on-a-Chip Models
Market Segmentation (by Application)
Drug Discovery and Toxicology
Basic Research
Physiological Research
Stem Cell Research and Regenerative Medicine
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Lungs in Vitro Model Market
Overview of the regional outlook of the Lungs in Vitro Model Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Lungs in Vitro Model Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Lungs in Vitro Model, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Lungs in Vitro Model
1.2 Key Market Segments
1.2.1 Lungs in Vitro Model Segment by Type
1.2.2 Lungs in Vitro Model Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 LUNGS IN VITRO MODEL MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Lungs in Vitro Model Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Lungs in Vitro Model Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 LUNGS IN VITRO MODEL MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Lungs in Vitro Model Product Life Cycle
3.3 Global Lungs in Vitro Model Sales by Manufacturers (2020-2025)
3.4 Global Lungs in Vitro Model Revenue Market Share by Manufacturers (2020-2025)
3.5 Lungs in Vitro Model Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Lungs in Vitro Model Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Lungs in Vitro Model Market Competitive Situation and Trends
3.8.1 Lungs in Vitro Model Market Concentration Rate
3.8.2 Global 5 and 10 Largest Lungs in Vitro Model Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 LUNGS IN VITRO MODEL INDUSTRY CHAIN ANALYSIS
4.1 Lungs in Vitro Model Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF LUNGS IN VITRO MODEL MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Lungs in Vitro Model Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Lungs in Vitro Model Market
5.7 ESG Ratings of Leading Companies
6 LUNGS IN VITRO MODEL MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Lungs in Vitro Model Sales Market Share by Type (2020-2025)
6.3 Global Lungs in Vitro Model Market Size by Type (2020-2025)
6.4 Global Lungs in Vitro Model Price by Type (2020-2025)
7 LUNGS IN VITRO MODEL MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Lungs in Vitro Model Market Sales by Application (2020-2025)
7.3 Global Lungs in Vitro Model Market Size (M USD) by Application (2020-2025)
7.4 Global Lungs in Vitro Model Sales Growth Rate by Application (2020-2025)
8 LUNGS IN VITRO MODEL MARKET SALES BY REGION
8.1 Global Lungs in Vitro Model Sales by Region
8.1.1 Global Lungs in Vitro Model Sales by Region
8.1.2 Global Lungs in Vitro Model Sales Market Share by Region
8.2 Global Lungs in Vitro Model Market Size by Region
8.2.1 Global Lungs in Vitro Model Market Size by Region
8.2.2 Global Lungs in Vitro Model Market Size by Region
8.3 North America
8.3.1 North America Lungs in Vitro Model Sales by Country
8.3.2 North America Lungs in Vitro Model Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Lungs in Vitro Model Sales by Country
8.4.2 Europe Lungs in Vitro Model Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Lungs in Vitro Model Sales by Region
8.5.2 Asia Pacific Lungs in Vitro Model Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Lungs in Vitro Model Sales by Country
8.6.2 South America Lungs in Vitro Model Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Lungs in Vitro Model Sales by Region
8.7.2 Middle East and Africa Lungs in Vitro Model Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 LUNGS IN VITRO MODEL MARKET PRODUCTION BY REGION
9.1 Global Production of Lungs in Vitro Model by Region(2020-2025)
9.2 Global Lungs in Vitro Model Revenue Market Share by Region (2020-2025)
9.3 Global Lungs in Vitro Model Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Lungs in Vitro Model Production
9.4.1 North America Lungs in Vitro Model Production Growth Rate (2020-2025)
9.4.2 North America Lungs in Vitro Model Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Lungs in Vitro Model Production
9.5.1 Europe Lungs in Vitro Model Production Growth Rate (2020-2025)
9.5.2 Europe Lungs in Vitro Model Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Lungs in Vitro Model Production (2020-2025)
9.6.1 Japan Lungs in Vitro Model Production Growth Rate (2020-2025)
9.6.2 Japan Lungs in Vitro Model Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Lungs in Vitro Model Production (2020-2025)
9.7.1 China Lungs in Vitro Model Production Growth Rate (2020-2025)
9.7.2 China Lungs in Vitro Model Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Mattek (Sartorius)
10.1.1 Mattek (Sartorius) Basic Information
10.1.2 Mattek (Sartorius) Lungs in Vitro Model Product Overview
10.1.3 Mattek (Sartorius) Lungs in Vitro Model Product Market Performance
10.1.4 Mattek (Sartorius) Business Overview
10.1.5 Mattek (Sartorius) SWOT Analysis
10.1.6 Mattek (Sartorius) Recent Developments
10.2 Dynamic42
10.2.1 Dynamic42 Basic Information
10.2.2 Dynamic42 Lungs in Vitro Model Product Overview
10.2.3 Dynamic42 Lungs in Vitro Model Product Market Performance
10.2.4 Dynamic42 Business Overview
10.2.5 Dynamic42 SWOT Analysis
10.2.6 Dynamic42 Recent Developments
10.3 SynVivo
10.3.1 SynVivo Basic Information
10.3.2 SynVivo Lungs in Vitro Model Product Overview
10.3.3 SynVivo Lungs in Vitro Model Product Market Performance
10.3.4 SynVivo Business Overview
10.3.5 SynVivo SWOT Analysis
10.3.6 SynVivo Recent Developments
10.4 Lonza
10.4.1 Lonza Basic Information
10.4.2 Lonza Lungs in Vitro Model Product Overview
10.4.3 Lonza Lungs in Vitro Model Product Market Performance
10.4.4 Lonza Business Overview
10.4.5 Lonza Recent Developments
10.5 Epithelix
10.5.1 Epithelix Basic Information
10.5.2 Epithelix Lungs in Vitro Model Product Overview
10.5.3 Epithelix Lungs in Vitro Model Product Market Performance
10.5.4 Epithelix Business Overview
10.5.5 Epithelix Recent Developments
10.6 Oncotheis
10.6.1 Oncotheis Basic Information
10.6.2 Oncotheis Lungs in Vitro Model Product Overview
10.6.3 Oncotheis Lungs in Vitro Model Product Market Performance
10.6.4 Oncotheis Business Overview
10.6.5 Oncotheis Recent Developments
10.7 Emulate
10.7.1 Emulate Basic Information
10.7.2 Emulate Lungs in Vitro Model Product Overview
10.7.3 Emulate Lungs in Vitro Model Product Market Performance
10.7.4 Emulate Business Overview
10.7.5 Emulate Recent Developments
10.8 Mimetas
10.8.1 Mimetas Basic Information
10.8.2 Mimetas Lungs in Vitro Model Product Overview
10.8.3 Mimetas Lungs in Vitro Model Product Market Performance
10.8.4 Mimetas Business Overview
10.8.5 Mimetas Recent Developments
10.9 Tissuse
10.9.1 Tissuse Basic Information
10.9.2 Tissuse Lungs in Vitro Model Product Overview
10.9.3 Tissuse Lungs in Vitro Model Product Market Performance
10.9.4 Tissuse Business Overview
10.9.5 Tissuse Recent Developments
10.10 Insphero
10.10.1 Insphero Basic Information
10.10.2 Insphero Lungs in Vitro Model Product Overview
10.10.3 Insphero Lungs in Vitro Model Product Market Performance
10.10.4 Insphero Business Overview
10.10.5 Insphero Recent Developments
10.11 CN Bio Innovations
10.11.1 CN Bio Innovations Basic Information
10.11.2 CN Bio Innovations Lungs in Vitro Model Product Overview
10.11.3 CN Bio Innovations Lungs in Vitro Model Product Market Performance
10.11.4 CN Bio Innovations Business Overview
10.11.5 CN Bio Innovations Recent Developments
10.12 AlveoliX
10.12.1 AlveoliX Basic Information
10.12.2 AlveoliX Lungs in Vitro Model Product Overview
10.12.3 AlveoliX Lungs in Vitro Model Product Market Performance
10.12.4 AlveoliX Business Overview
10.12.5 AlveoliX Recent Developments
11 LUNGS IN VITRO MODEL MARKET FORECAST BY REGION
11.1 Global Lungs in Vitro Model Market Size Forecast
11.2 Global Lungs in Vitro Model Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Lungs in Vitro Model Market Size Forecast by Country
11.2.3 Asia Pacific Lungs in Vitro Model Market Size Forecast by Region
11.2.4 South America Lungs in Vitro Model Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Lungs in Vitro Model by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Lungs in Vitro Model Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Lungs in Vitro Model by Type (2026-2035)
12.1.2 Global Lungs in Vitro Model Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Lungs in Vitro Model by Type (2026-2035)
12.2 Global Lungs in Vitro Model Market Forecast by Application (2026-2035)
12.2.1 Global Lungs in Vitro Model Sales (K Units) Forecast by Application
12.2.2 Global Lungs in Vitro Model Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Lungs in Vitro Model
1.2 Key Market Segments
1.2.1 Lungs in Vitro Model Segment by Type
1.2.2 Lungs in Vitro Model Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 LUNGS IN VITRO MODEL MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Lungs in Vitro Model Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Lungs in Vitro Model Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 LUNGS IN VITRO MODEL MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Lungs in Vitro Model Product Life Cycle
3.3 Global Lungs in Vitro Model Sales by Manufacturers (2020-2025)
3.4 Global Lungs in Vitro Model Revenue Market Share by Manufacturers (2020-2025)
3.5 Lungs in Vitro Model Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Lungs in Vitro Model Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Lungs in Vitro Model Market Competitive Situation and Trends
3.8.1 Lungs in Vitro Model Market Concentration Rate
3.8.2 Global 5 and 10 Largest Lungs in Vitro Model Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 LUNGS IN VITRO MODEL INDUSTRY CHAIN ANALYSIS
4.1 Lungs in Vitro Model Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF LUNGS IN VITRO MODEL MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Lungs in Vitro Model Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Lungs in Vitro Model Market
5.7 ESG Ratings of Leading Companies
6 LUNGS IN VITRO MODEL MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Lungs in Vitro Model Sales Market Share by Type (2020-2025)
6.3 Global Lungs in Vitro Model Market Size by Type (2020-2025)
6.4 Global Lungs in Vitro Model Price by Type (2020-2025)
7 LUNGS IN VITRO MODEL MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Lungs in Vitro Model Market Sales by Application (2020-2025)
7.3 Global Lungs in Vitro Model Market Size (M USD) by Application (2020-2025)
7.4 Global Lungs in Vitro Model Sales Growth Rate by Application (2020-2025)
8 LUNGS IN VITRO MODEL MARKET SALES BY REGION
8.1 Global Lungs in Vitro Model Sales by Region
8.1.1 Global Lungs in Vitro Model Sales by Region
8.1.2 Global Lungs in Vitro Model Sales Market Share by Region
8.2 Global Lungs in Vitro Model Market Size by Region
8.2.1 Global Lungs in Vitro Model Market Size by Region
8.2.2 Global Lungs in Vitro Model Market Size by Region
8.3 North America
8.3.1 North America Lungs in Vitro Model Sales by Country
8.3.2 North America Lungs in Vitro Model Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Lungs in Vitro Model Sales by Country
8.4.2 Europe Lungs in Vitro Model Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Lungs in Vitro Model Sales by Region
8.5.2 Asia Pacific Lungs in Vitro Model Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Lungs in Vitro Model Sales by Country
8.6.2 South America Lungs in Vitro Model Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Lungs in Vitro Model Sales by Region
8.7.2 Middle East and Africa Lungs in Vitro Model Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 LUNGS IN VITRO MODEL MARKET PRODUCTION BY REGION
9.1 Global Production of Lungs in Vitro Model by Region(2020-2025)
9.2 Global Lungs in Vitro Model Revenue Market Share by Region (2020-2025)
9.3 Global Lungs in Vitro Model Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Lungs in Vitro Model Production
9.4.1 North America Lungs in Vitro Model Production Growth Rate (2020-2025)
9.4.2 North America Lungs in Vitro Model Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Lungs in Vitro Model Production
9.5.1 Europe Lungs in Vitro Model Production Growth Rate (2020-2025)
9.5.2 Europe Lungs in Vitro Model Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Lungs in Vitro Model Production (2020-2025)
9.6.1 Japan Lungs in Vitro Model Production Growth Rate (2020-2025)
9.6.2 Japan Lungs in Vitro Model Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Lungs in Vitro Model Production (2020-2025)
9.7.1 China Lungs in Vitro Model Production Growth Rate (2020-2025)
9.7.2 China Lungs in Vitro Model Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Mattek (Sartorius)
10.1.1 Mattek (Sartorius) Basic Information
10.1.2 Mattek (Sartorius) Lungs in Vitro Model Product Overview
10.1.3 Mattek (Sartorius) Lungs in Vitro Model Product Market Performance
10.1.4 Mattek (Sartorius) Business Overview
10.1.5 Mattek (Sartorius) SWOT Analysis
10.1.6 Mattek (Sartorius) Recent Developments
10.2 Dynamic42
10.2.1 Dynamic42 Basic Information
10.2.2 Dynamic42 Lungs in Vitro Model Product Overview
10.2.3 Dynamic42 Lungs in Vitro Model Product Market Performance
10.2.4 Dynamic42 Business Overview
10.2.5 Dynamic42 SWOT Analysis
10.2.6 Dynamic42 Recent Developments
10.3 SynVivo
10.3.1 SynVivo Basic Information
10.3.2 SynVivo Lungs in Vitro Model Product Overview
10.3.3 SynVivo Lungs in Vitro Model Product Market Performance
10.3.4 SynVivo Business Overview
10.3.5 SynVivo SWOT Analysis
10.3.6 SynVivo Recent Developments
10.4 Lonza
10.4.1 Lonza Basic Information
10.4.2 Lonza Lungs in Vitro Model Product Overview
10.4.3 Lonza Lungs in Vitro Model Product Market Performance
10.4.4 Lonza Business Overview
10.4.5 Lonza Recent Developments
10.5 Epithelix
10.5.1 Epithelix Basic Information
10.5.2 Epithelix Lungs in Vitro Model Product Overview
10.5.3 Epithelix Lungs in Vitro Model Product Market Performance
10.5.4 Epithelix Business Overview
10.5.5 Epithelix Recent Developments
10.6 Oncotheis
10.6.1 Oncotheis Basic Information
10.6.2 Oncotheis Lungs in Vitro Model Product Overview
10.6.3 Oncotheis Lungs in Vitro Model Product Market Performance
10.6.4 Oncotheis Business Overview
10.6.5 Oncotheis Recent Developments
10.7 Emulate
10.7.1 Emulate Basic Information
10.7.2 Emulate Lungs in Vitro Model Product Overview
10.7.3 Emulate Lungs in Vitro Model Product Market Performance
10.7.4 Emulate Business Overview
10.7.5 Emulate Recent Developments
10.8 Mimetas
10.8.1 Mimetas Basic Information
10.8.2 Mimetas Lungs in Vitro Model Product Overview
10.8.3 Mimetas Lungs in Vitro Model Product Market Performance
10.8.4 Mimetas Business Overview
10.8.5 Mimetas Recent Developments
10.9 Tissuse
10.9.1 Tissuse Basic Information
10.9.2 Tissuse Lungs in Vitro Model Product Overview
10.9.3 Tissuse Lungs in Vitro Model Product Market Performance
10.9.4 Tissuse Business Overview
10.9.5 Tissuse Recent Developments
10.10 Insphero
10.10.1 Insphero Basic Information
10.10.2 Insphero Lungs in Vitro Model Product Overview
10.10.3 Insphero Lungs in Vitro Model Product Market Performance
10.10.4 Insphero Business Overview
10.10.5 Insphero Recent Developments
10.11 CN Bio Innovations
10.11.1 CN Bio Innovations Basic Information
10.11.2 CN Bio Innovations Lungs in Vitro Model Product Overview
10.11.3 CN Bio Innovations Lungs in Vitro Model Product Market Performance
10.11.4 CN Bio Innovations Business Overview
10.11.5 CN Bio Innovations Recent Developments
10.12 AlveoliX
10.12.1 AlveoliX Basic Information
10.12.2 AlveoliX Lungs in Vitro Model Product Overview
10.12.3 AlveoliX Lungs in Vitro Model Product Market Performance
10.12.4 AlveoliX Business Overview
10.12.5 AlveoliX Recent Developments
11 LUNGS IN VITRO MODEL MARKET FORECAST BY REGION
11.1 Global Lungs in Vitro Model Market Size Forecast
11.2 Global Lungs in Vitro Model Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Lungs in Vitro Model Market Size Forecast by Country
11.2.3 Asia Pacific Lungs in Vitro Model Market Size Forecast by Region
11.2.4 South America Lungs in Vitro Model Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Lungs in Vitro Model by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Lungs in Vitro Model Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Lungs in Vitro Model by Type (2026-2035)
12.1.2 Global Lungs in Vitro Model Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Lungs in Vitro Model by Type (2026-2035)
12.2 Global Lungs in Vitro Model Market Forecast by Application (2026-2035)
12.2.1 Global Lungs in Vitro Model Sales (K Units) Forecast by Application
12.2.2 Global Lungs in Vitro Model Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Lungs in Vitro Model Market Size by Type (M USD)
Table 4. Global Lungs in Vitro Model Market Size by Application
Table 5. Lungs in Vitro Model Market Size Comparison by Region (M USD)
Table 6. Global Lungs in Vitro Model Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Lungs in Vitro Model Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Lungs in Vitro Model Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Lungs in Vitro Model Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lungs in Vitro Model as of 2025)
Table 11. Global Market Lungs in Vitro Model Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Lungs in Vitro Model Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Lungs in Vitro Model Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Lungs in Vitro Model Sales by Type (K Units)
Table 27. Global Lungs in Vitro Model Market Size by Type (M USD)
Table 28. Global Lungs in Vitro Model Sales (K Units) by Type (2020-2025)
Table 29. Global Lungs in Vitro Model Sales Market Share by Type (2020-2025)
Table 30. Global Lungs in Vitro Model Market Size (M USD) by Type (2020-2025)
Table 31. Global Lungs in Vitro Model Market Share by Type (2020-2025)
Table 32. Global Lungs in Vitro Model Price (USD/Unit) by Type (2020-2025)
Table 33. Global Lungs in Vitro Model Sales (K Units) by Application
Table 34. Global Lungs in Vitro Model Market Size by Application
Table 35. Global Lungs in Vitro Model Sales by Application (2020-2025) & (K Units)
Table 36. Global Lungs in Vitro Model Sales Market Share by Application (2020-2025)
Table 37. Global Lungs in Vitro Model Market Size by Application (2020-2025) & (M USD)
Table 38. Global Lungs in Vitro Model Market Share by Application (2020-2025)
Table 39. Global Lungs in Vitro Model Sales Growth Rate by Application (2020-2025)
Table 40. Global Lungs in Vitro Model Sales by Region (2020-2025) & (K Units)
Table 41. Global Lungs in Vitro Model Sales Market Share by Region (2020-2025)
Table 42. Global Lungs in Vitro Model Market Size by Region (2020-2025) & (M USD)
Table 43. Global Lungs in Vitro Model Market Size by Region (2020-2025)
Table 44. North America Lungs in Vitro Model Sales by Country (2020-2025) & (K Units)
Table 45. North America Lungs in Vitro Model Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Lungs in Vitro Model Sales by Country (2020-2025) & (K Units)
Table 47. Europe Lungs in Vitro Model Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Lungs in Vitro Model Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Lungs in Vitro Model Market Size by Region (2020-2025) & (M USD)
Table 50. South America Lungs in Vitro Model Sales by Country (2020-2025) & (K Units)
Table 51. South America Lungs in Vitro Model Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Lungs in Vitro Model Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Lungs in Vitro Model Market Size by Region (2020-2025) & (M USD)
Table 54. Global Lungs in Vitro Model Production (K Units) by Region(2020-2025)
Table 55. Global Lungs in Vitro Model Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Lungs in Vitro Model Revenue Market Share by Region (2020-2025)
Table 57. Global Lungs in Vitro Model Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Lungs in Vitro Model Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Lungs in Vitro Model Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Lungs in Vitro Model Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Lungs in Vitro Model Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Mattek (Sartorius) Basic Information
Table 63. Mattek (Sartorius) Lungs in Vitro Model Product Overview
Table 64. Mattek (Sartorius) Lungs in Vitro Model Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Mattek (Sartorius) Business Overview
Table 66. Mattek (Sartorius) SWOT Analysis
Table 67. Mattek (Sartorius) Recent Developments
Table 68. Dynamic42 Basic Information
Table 69. Dynamic42 Lungs in Vitro Model Product Overview
Table 70. Dynamic42 Lungs in Vitro Model Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Dynamic42 Business Overview
Table 72. Dynamic42 SWOT Analysis
Table 73. Dynamic42 Recent Developments
Table 74. SynVivo Basic Information
Table 75. SynVivo Lungs in Vitro Model Product Overview
Table 76. SynVivo Lungs in Vitro Model Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. SynVivo Business Overview
Table 78. SynVivo SWOT Analysis
Table 79. SynVivo Recent Developments
Table 80. Lonza Basic Information
Table 81. Lonza Lungs in Vitro Model Product Overview
Table 82. Lonza Lungs in Vitro Model Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Lonza Business Overview
Table 84. Lonza Recent Developments
Table 85. Epithelix Basic Information
Table 86. Epithelix Lungs in Vitro Model Product Overview
Table 87. Epithelix Lungs in Vitro Model Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Epithelix Business Overview
Table 89. Epithelix Recent Developments
Table 90. Oncotheis Basic Information
Table 91. Oncotheis Lungs in Vitro Model Product Overview
Table 92. Oncotheis Lungs in Vitro Model Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Oncotheis Business Overview
Table 94. Oncotheis Recent Developments
Table 95. Emulate Basic Information
Table 96. Emulate Lungs in Vitro Model Product Overview
Table 97. Emulate Lungs in Vitro Model Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Emulate Business Overview
Table 99. Emulate Recent Developments
Table 100. Mimetas Basic Information
Table 101. Mimetas Lungs in Vitro Model Product Overview
Table 102. Mimetas Lungs in Vitro Model Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Mimetas Business Overview
Table 104. Mimetas Recent Developments
Table 105. Tissuse Basic Information
Table 106. Tissuse Lungs in Vitro Model Product Overview
Table 107. Tissuse Lungs in Vitro Model Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Tissuse Business Overview
Table 109. Tissuse Recent Developments
Table 110. Insphero Basic Information
Table 111. Insphero Lungs in Vitro Model Product Overview
Table 112. Insphero Lungs in Vitro Model Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Insphero Business Overview
Table 114. Insphero Recent Developments
Table 115. CN Bio Innovations Basic Information
Table 116. CN Bio Innovations Lungs in Vitro Model Product Overview
Table 117. CN Bio Innovations Lungs in Vitro Model Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. CN Bio Innovations Business Overview
Table 119. CN Bio Innovations Recent Developments
Table 120. AlveoliX Basic Information
Table 121. AlveoliX Lungs in Vitro Model Product Overview
Table 122. AlveoliX Lungs in Vitro Model Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. AlveoliX Business Overview
Table 124. AlveoliX Recent Developments
Table 125. Global Lungs in Vitro Model Sales Forecast by Region (2026-2035) & (K Units)
Table 126. Global Lungs in Vitro Model Market Size Forecast by Region (2026-2035) & (M USD)
Table 127. North America Lungs in Vitro Model Sales Forecast by Country (2026-2035) & (K Units)
Table 128. North America Lungs in Vitro Model Market Size Forecast by Country (2026-2035) & (M USD)
Table 129. Europe Lungs in Vitro Model Sales Forecast by Country (2026-2035) & (K Units)
Table 130. Europe Lungs in Vitro Model Market Size Forecast by Country (2026-2035) & (M USD)
Table 131. Asia Pacific Lungs in Vitro Model Sales Forecast by Region (2026-2035) & (K Units)
Table 132. Asia Pacific Lungs in Vitro Model Market Size Forecast by Region (2026-2035) & (M USD)
Table 133. South America Lungs in Vitro Model Sales Forecast by Country (2026-2035) & (K Units)
Table 134. South America Lungs in Vitro Model Market Size Forecast by Country (2026-2035) & (M USD)
Table 135. Middle East and Africa Lungs in Vitro Model Sales Forecast by Country (2026-2035) & (Units)
Table 136. Middle East and Africa Lungs in Vitro Model Market Size Forecast by Country (2026-2035) & (M USD)
Table 137. Global Lungs in Vitro Model Sales Forecast by Type (2026-2035) & (K Units)
Table 138. Global Lungs in Vitro Model Market Size Forecast by Type (2026-2035) & (M USD)
Table 139. Global Lungs in Vitro Model Price Forecast by Type (2026-2035) & (USD/Unit)
Table 140. Global Lungs in Vitro Model Sales (K Units) Forecast by Application (2026-2035)
Table 141. Global Lungs in Vitro Model Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Lungs in Vitro Model Market Size by Type (M USD)
Table 4. Global Lungs in Vitro Model Market Size by Application
Table 5. Lungs in Vitro Model Market Size Comparison by Region (M USD)
Table 6. Global Lungs in Vitro Model Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Lungs in Vitro Model Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Lungs in Vitro Model Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Lungs in Vitro Model Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lungs in Vitro Model as of 2025)
Table 11. Global Market Lungs in Vitro Model Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Lungs in Vitro Model Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Lungs in Vitro Model Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Lungs in Vitro Model Sales by Type (K Units)
Table 27. Global Lungs in Vitro Model Market Size by Type (M USD)
Table 28. Global Lungs in Vitro Model Sales (K Units) by Type (2020-2025)
Table 29. Global Lungs in Vitro Model Sales Market Share by Type (2020-2025)
Table 30. Global Lungs in Vitro Model Market Size (M USD) by Type (2020-2025)
Table 31. Global Lungs in Vitro Model Market Share by Type (2020-2025)
Table 32. Global Lungs in Vitro Model Price (USD/Unit) by Type (2020-2025)
Table 33. Global Lungs in Vitro Model Sales (K Units) by Application
Table 34. Global Lungs in Vitro Model Market Size by Application
Table 35. Global Lungs in Vitro Model Sales by Application (2020-2025) & (K Units)
Table 36. Global Lungs in Vitro Model Sales Market Share by Application (2020-2025)
Table 37. Global Lungs in Vitro Model Market Size by Application (2020-2025) & (M USD)
Table 38. Global Lungs in Vitro Model Market Share by Application (2020-2025)
Table 39. Global Lungs in Vitro Model Sales Growth Rate by Application (2020-2025)
Table 40. Global Lungs in Vitro Model Sales by Region (2020-2025) & (K Units)
Table 41. Global Lungs in Vitro Model Sales Market Share by Region (2020-2025)
Table 42. Global Lungs in Vitro Model Market Size by Region (2020-2025) & (M USD)
Table 43. Global Lungs in Vitro Model Market Size by Region (2020-2025)
Table 44. North America Lungs in Vitro Model Sales by Country (2020-2025) & (K Units)
Table 45. North America Lungs in Vitro Model Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Lungs in Vitro Model Sales by Country (2020-2025) & (K Units)
Table 47. Europe Lungs in Vitro Model Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Lungs in Vitro Model Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Lungs in Vitro Model Market Size by Region (2020-2025) & (M USD)
Table 50. South America Lungs in Vitro Model Sales by Country (2020-2025) & (K Units)
Table 51. South America Lungs in Vitro Model Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Lungs in Vitro Model Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Lungs in Vitro Model Market Size by Region (2020-2025) & (M USD)
Table 54. Global Lungs in Vitro Model Production (K Units) by Region(2020-2025)
Table 55. Global Lungs in Vitro Model Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Lungs in Vitro Model Revenue Market Share by Region (2020-2025)
Table 57. Global Lungs in Vitro Model Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Lungs in Vitro Model Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Lungs in Vitro Model Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Lungs in Vitro Model Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Lungs in Vitro Model Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Mattek (Sartorius) Basic Information
Table 63. Mattek (Sartorius) Lungs in Vitro Model Product Overview
Table 64. Mattek (Sartorius) Lungs in Vitro Model Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Mattek (Sartorius) Business Overview
Table 66. Mattek (Sartorius) SWOT Analysis
Table 67. Mattek (Sartorius) Recent Developments
Table 68. Dynamic42 Basic Information
Table 69. Dynamic42 Lungs in Vitro Model Product Overview
Table 70. Dynamic42 Lungs in Vitro Model Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Dynamic42 Business Overview
Table 72. Dynamic42 SWOT Analysis
Table 73. Dynamic42 Recent Developments
Table 74. SynVivo Basic Information
Table 75. SynVivo Lungs in Vitro Model Product Overview
Table 76. SynVivo Lungs in Vitro Model Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. SynVivo Business Overview
Table 78. SynVivo SWOT Analysis
Table 79. SynVivo Recent Developments
Table 80. Lonza Basic Information
Table 81. Lonza Lungs in Vitro Model Product Overview
Table 82. Lonza Lungs in Vitro Model Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Lonza Business Overview
Table 84. Lonza Recent Developments
Table 85. Epithelix Basic Information
Table 86. Epithelix Lungs in Vitro Model Product Overview
Table 87. Epithelix Lungs in Vitro Model Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Epithelix Business Overview
Table 89. Epithelix Recent Developments
Table 90. Oncotheis Basic Information
Table 91. Oncotheis Lungs in Vitro Model Product Overview
Table 92. Oncotheis Lungs in Vitro Model Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Oncotheis Business Overview
Table 94. Oncotheis Recent Developments
Table 95. Emulate Basic Information
Table 96. Emulate Lungs in Vitro Model Product Overview
Table 97. Emulate Lungs in Vitro Model Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Emulate Business Overview
Table 99. Emulate Recent Developments
Table 100. Mimetas Basic Information
Table 101. Mimetas Lungs in Vitro Model Product Overview
Table 102. Mimetas Lungs in Vitro Model Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Mimetas Business Overview
Table 104. Mimetas Recent Developments
Table 105. Tissuse Basic Information
Table 106. Tissuse Lungs in Vitro Model Product Overview
Table 107. Tissuse Lungs in Vitro Model Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Tissuse Business Overview
Table 109. Tissuse Recent Developments
Table 110. Insphero Basic Information
Table 111. Insphero Lungs in Vitro Model Product Overview
Table 112. Insphero Lungs in Vitro Model Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Insphero Business Overview
Table 114. Insphero Recent Developments
Table 115. CN Bio Innovations Basic Information
Table 116. CN Bio Innovations Lungs in Vitro Model Product Overview
Table 117. CN Bio Innovations Lungs in Vitro Model Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. CN Bio Innovations Business Overview
Table 119. CN Bio Innovations Recent Developments
Table 120. AlveoliX Basic Information
Table 121. AlveoliX Lungs in Vitro Model Product Overview
Table 122. AlveoliX Lungs in Vitro Model Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. AlveoliX Business Overview
Table 124. AlveoliX Recent Developments
Table 125. Global Lungs in Vitro Model Sales Forecast by Region (2026-2035) & (K Units)
Table 126. Global Lungs in Vitro Model Market Size Forecast by Region (2026-2035) & (M USD)
Table 127. North America Lungs in Vitro Model Sales Forecast by Country (2026-2035) & (K Units)
Table 128. North America Lungs in Vitro Model Market Size Forecast by Country (2026-2035) & (M USD)
Table 129. Europe Lungs in Vitro Model Sales Forecast by Country (2026-2035) & (K Units)
Table 130. Europe Lungs in Vitro Model Market Size Forecast by Country (2026-2035) & (M USD)
Table 131. Asia Pacific Lungs in Vitro Model Sales Forecast by Region (2026-2035) & (K Units)
Table 132. Asia Pacific Lungs in Vitro Model Market Size Forecast by Region (2026-2035) & (M USD)
Table 133. South America Lungs in Vitro Model Sales Forecast by Country (2026-2035) & (K Units)
Table 134. South America Lungs in Vitro Model Market Size Forecast by Country (2026-2035) & (M USD)
Table 135. Middle East and Africa Lungs in Vitro Model Sales Forecast by Country (2026-2035) & (Units)
Table 136. Middle East and Africa Lungs in Vitro Model Market Size Forecast by Country (2026-2035) & (M USD)
Table 137. Global Lungs in Vitro Model Sales Forecast by Type (2026-2035) & (K Units)
Table 138. Global Lungs in Vitro Model Market Size Forecast by Type (2026-2035) & (M USD)
Table 139. Global Lungs in Vitro Model Price Forecast by Type (2026-2035) & (USD/Unit)
Table 140. Global Lungs in Vitro Model Sales (K Units) Forecast by Application (2026-2035)
Table 141. Global Lungs in Vitro Model Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Lungs in Vitro Model
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Lungs in Vitro Model Market Size (M USD), 2025-2035
Figure 5. Global Lungs in Vitro Model Market Size (M USD) (2020-2035)
Figure 6. Global Lungs in Vitro Model Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Lungs in Vitro Model Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Lungs in Vitro Model Product Life Cycle
Figure 13. Lungs in Vitro Model Sales Share by Manufacturers in 2025
Figure 14. Global Lungs in Vitro Model Revenue Share by Manufacturers in 2025
Figure 15. Lungs in Vitro Model Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Lungs in Vitro Model Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Lungs in Vitro Model Revenue in 2025
Figure 18. Industry Chain Map of Lungs in Vitro Model
Figure 19. Global Lungs in Vitro Model Market PEST Analysis
Figure 20. Global Lungs in Vitro Model Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Lungs in Vitro Model Market Share by Type
Figure 27. Sales Market Share of Lungs in Vitro Model by Type (2020-2025)
Figure 28. Sales Market Share of Lungs in Vitro Model by Type in 2025
Figure 29. Market Share of Lungs in Vitro Model by Type (2020-2025)
Figure 30. Market Share of Lungs in Vitro Model by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Lungs in Vitro Model Market Share by Application
Figure 33. Global Lungs in Vitro Model Sales Market Share by Application (2020-2025)
Figure 34. Global Lungs in Vitro Model Sales Market Share by Application in 2025
Figure 35. Global Lungs in Vitro Model Market Share by Application (2020-2025)
Figure 36. Global Lungs in Vitro Model Market Share by Application in 2025
Figure 37. Global Lungs in Vitro Model Sales Growth Rate by Application (2020-2025)
Figure 38. Global Lungs in Vitro Model Sales Market Share by Region (2020-2025)
Figure 39. Global Lungs in Vitro Model Market Size by Region (2020-2025)
Figure 40. North America Lungs in Vitro Model Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Lungs in Vitro Model Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Lungs in Vitro Model Sales Market Share by Country in 2024
Figure 43. North America Lungs in Vitro Model Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Lungs in Vitro Model Market Size by Country in 2024
Figure 45. U.S. Lungs in Vitro Model Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Lungs in Vitro Model Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Lungs in Vitro Model Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Lungs in Vitro Model Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Lungs in Vitro Model Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Lungs in Vitro Model Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Lungs in Vitro Model Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Lungs in Vitro Model Sales Market Share by Country in 2024
Figure 53. Europe Lungs in Vitro Model Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Lungs in Vitro Model Market Size by Country in 2024
Figure 55. Germany Lungs in Vitro Model Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Lungs in Vitro Model Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Lungs in Vitro Model Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Lungs in Vitro Model Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Lungs in Vitro Model Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Lungs in Vitro Model Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Lungs in Vitro Model Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Lungs in Vitro Model Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Lungs in Vitro Model Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Lungs in Vitro Model Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Lungs in Vitro Model Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Lungs in Vitro Model Sales Market Share by Region in 2024
Figure 67. Asia Pacific Lungs in Vitro Model Market Size by Region in 2024
Figure 68. China Lungs in Vitro Model Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Lungs in Vitro Model Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Lungs in Vitro Model Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Lungs in Vitro Model Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Lungs in Vitro Model Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Lungs in Vitro Model Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Lungs in Vitro Model Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Lungs in Vitro Model Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Lungs in Vitro Model Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Lungs in Vitro Model Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Lungs in Vitro Model Sales and Growth Rate (K Units)
Figure 79. South America Lungs in Vitro Model Sales Market Share by Country in 2024
Figure 80. South America Lungs in Vitro Model Market Size and Growth Rate (M USD)
Figure 81. South America Lungs in Vitro Model Market Size by Country in 2024
Figure 82. Brazil Lungs in Vitro Model Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Lungs in Vitro Model Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Lungs in Vitro Model Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Lungs in Vitro Model Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Lungs in Vitro Model Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Lungs in Vitro Model Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Lungs in Vitro Model Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Lungs in Vitro Model Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Lungs in Vitro Model Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Lungs in Vitro Model Market Size by Region in 2024
Figure 92. Saudi Arabia Lungs in Vitro Model Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Lungs in Vitro Model Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Lungs in Vitro Model Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Lungs in Vitro Model Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Lungs in Vitro Model Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Lungs in Vitro Model Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Lungs in Vitro Model Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Lungs in Vitro Model Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Lungs in Vitro Model Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Lungs in Vitro Model Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Lungs in Vitro Model Production Market Share by Region (2020-2025)
Figure 103. North America Lungs in Vitro Model Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Lungs in Vitro Model Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Lungs in Vitro Model Production (K Units) Growth Rate (2020-2025)
Figure 106. China Lungs in Vitro Model Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Lungs in Vitro Model Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Lungs in Vitro Model Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Lungs in Vitro Model Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Lungs in Vitro Model Market Share Forecast by Type (2026-2035)
Figure 111. Global Lungs in Vitro Model Sales Forecast by Application (2026-2035)
Figure 112. Global Lungs in Vitro Model Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Lungs in Vitro Model
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Lungs in Vitro Model Market Size (M USD), 2025-2035
Figure 5. Global Lungs in Vitro Model Market Size (M USD) (2020-2035)
Figure 6. Global Lungs in Vitro Model Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Lungs in Vitro Model Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Lungs in Vitro Model Product Life Cycle
Figure 13. Lungs in Vitro Model Sales Share by Manufacturers in 2025
Figure 14. Global Lungs in Vitro Model Revenue Share by Manufacturers in 2025
Figure 15. Lungs in Vitro Model Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Lungs in Vitro Model Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Lungs in Vitro Model Revenue in 2025
Figure 18. Industry Chain Map of Lungs in Vitro Model
Figure 19. Global Lungs in Vitro Model Market PEST Analysis
Figure 20. Global Lungs in Vitro Model Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Lungs in Vitro Model Market Share by Type
Figure 27. Sales Market Share of Lungs in Vitro Model by Type (2020-2025)
Figure 28. Sales Market Share of Lungs in Vitro Model by Type in 2025
Figure 29. Market Share of Lungs in Vitro Model by Type (2020-2025)
Figure 30. Market Share of Lungs in Vitro Model by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Lungs in Vitro Model Market Share by Application
Figure 33. Global Lungs in Vitro Model Sales Market Share by Application (2020-2025)
Figure 34. Global Lungs in Vitro Model Sales Market Share by Application in 2025
Figure 35. Global Lungs in Vitro Model Market Share by Application (2020-2025)
Figure 36. Global Lungs in Vitro Model Market Share by Application in 2025
Figure 37. Global Lungs in Vitro Model Sales Growth Rate by Application (2020-2025)
Figure 38. Global Lungs in Vitro Model Sales Market Share by Region (2020-2025)
Figure 39. Global Lungs in Vitro Model Market Size by Region (2020-2025)
Figure 40. North America Lungs in Vitro Model Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Lungs in Vitro Model Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Lungs in Vitro Model Sales Market Share by Country in 2024
Figure 43. North America Lungs in Vitro Model Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Lungs in Vitro Model Market Size by Country in 2024
Figure 45. U.S. Lungs in Vitro Model Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Lungs in Vitro Model Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Lungs in Vitro Model Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Lungs in Vitro Model Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Lungs in Vitro Model Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Lungs in Vitro Model Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Lungs in Vitro Model Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Lungs in Vitro Model Sales Market Share by Country in 2024
Figure 53. Europe Lungs in Vitro Model Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Lungs in Vitro Model Market Size by Country in 2024
Figure 55. Germany Lungs in Vitro Model Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Lungs in Vitro Model Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Lungs in Vitro Model Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Lungs in Vitro Model Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Lungs in Vitro Model Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Lungs in Vitro Model Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Lungs in Vitro Model Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Lungs in Vitro Model Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Lungs in Vitro Model Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Lungs in Vitro Model Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Lungs in Vitro Model Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Lungs in Vitro Model Sales Market Share by Region in 2024
Figure 67. Asia Pacific Lungs in Vitro Model Market Size by Region in 2024
Figure 68. China Lungs in Vitro Model Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Lungs in Vitro Model Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Lungs in Vitro Model Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Lungs in Vitro Model Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Lungs in Vitro Model Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Lungs in Vitro Model Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Lungs in Vitro Model Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Lungs in Vitro Model Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Lungs in Vitro Model Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Lungs in Vitro Model Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Lungs in Vitro Model Sales and Growth Rate (K Units)
Figure 79. South America Lungs in Vitro Model Sales Market Share by Country in 2024
Figure 80. South America Lungs in Vitro Model Market Size and Growth Rate (M USD)
Figure 81. South America Lungs in Vitro Model Market Size by Country in 2024
Figure 82. Brazil Lungs in Vitro Model Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Lungs in Vitro Model Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Lungs in Vitro Model Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Lungs in Vitro Model Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Lungs in Vitro Model Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Lungs in Vitro Model Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Lungs in Vitro Model Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Lungs in Vitro Model Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Lungs in Vitro Model Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Lungs in Vitro Model Market Size by Region in 2024
Figure 92. Saudi Arabia Lungs in Vitro Model Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Lungs in Vitro Model Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Lungs in Vitro Model Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Lungs in Vitro Model Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Lungs in Vitro Model Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Lungs in Vitro Model Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Lungs in Vitro Model Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Lungs in Vitro Model Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Lungs in Vitro Model Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Lungs in Vitro Model Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Lungs in Vitro Model Production Market Share by Region (2020-2025)
Figure 103. North America Lungs in Vitro Model Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Lungs in Vitro Model Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Lungs in Vitro Model Production (K Units) Growth Rate (2020-2025)
Figure 106. China Lungs in Vitro Model Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Lungs in Vitro Model Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Lungs in Vitro Model Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Lungs in Vitro Model Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Lungs in Vitro Model Market Share Forecast by Type (2026-2035)
Figure 111. Global Lungs in Vitro Model Sales Forecast by Application (2026-2035)
Figure 112. Global Lungs in Vitro Model Market Share Forecast by Application (2026-2035)
